Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

Emerge Weight Loss vs Novi

An in-depth comparison of two leading GLP-1 Providers

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.6

Emerge Weight Loss

Best for patients committed to tirzepatide as their drug of choice
★★★3.8

Starting at $299/mo

CompoundedTirzepatideTelehealthPhysician supervised
Visit Emerge Weight Loss
8.6

Novi

Best for transparent all-in compounded GLP-1 pricing
★★★★4.3

Starting at $174/mo

CompoundedSemaglutideTirzepatideFree 2-Day Shipping
Visit Novi

Side-by-Side Comparison

FeatureEmerge Weight LossNovi
Overall Score7.6/108.6/10
Starting Price$299/mo$174/mo
Editorial Rating3.8 ★ /54.3 ★ /5
Features4 features5 features
States Available00
Compounded✓ Yes✓ Yes
Brand Name
FSA/HSA Accepted
FDA WarningsNoneNone

Pros & Cons

Emerge Weight Loss

Pros

  • Tirzepatide-focused (largest effect-size compounded GLP-1)
  • Wide dose range available
  • Physician-supervised telemedicine model

Cons

  • No semaglutide option — limits flexibility if tirzepatide tolerability is poor
  • Less brand recognition than Henry Meds, Mochi, or SkinnyRx

Novi

Pros

  • Transparent all-in monthly pricing — medication, clinician support, and shipping bundled with no hidden fees or membership add-ons
  • Both compounded semaglutide and tirzepatide available
  • Unlimited clinician messaging included at no extra cost
  • Free 2-day shipping on every refill

Cons

  • Compounded only — no FDA-approved Ozempic, Wegovy, Zepbound, or Mounjaro option
  • 3-month minimum commitment is non-refundable per Terms of Service unless a clinician deems treatment medically inappropriate
  • State availability and pharmacy partners not publicly listed — patients learn during intake which states and pharmacies serve them

Our Verdict

Winner: NoviScore: 8.6/10

Novi edges out Emerge Weight Loss with a higher overall score of 8.6/10 and is particularly strong for transparent all-in compounded GLP-1 pricing. Emerge Weight Loss remains a solid alternative, especially if you're looking for patients committed to tirzepatide as their drug of choice.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.